Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The skincare business is expected to regain momentum in the second half of the year, while the medical aesthetics segment is building a new growth curve [1] - The company reported a revenue of 5.52 billion yuan for 2025, a slight decrease of 0.4% year-on-year, and a net profit attributable to shareholders of 1.91 billion yuan, down 7.2% year-on-year [3][4] - The first half of 2025 saw a revenue of 3.11 billion yuan, up 22.5% year-on-year, while the second half experienced a decline of 19.8% [3][4] Revenue Performance - The company's professional skincare products generated revenue of 5.50 billion yuan in 2025, with functional skincare products accounting for 4.34 billion yuan, a year-on-year increase of 0.8% [4] - The revenue from the medical dressing segment was 1.16 billion yuan, down 4.8% year-on-year [4] - The company's main brand, 可复美, generated 4.47 billion yuan in revenue, a decrease of 1.6% year-on-year, while the 可丽金 brand saw a revenue increase of 9.2% to 0.92 billion yuan [4] Product and Brand Development - In 2025, the company launched the 可复美胶原棒 2.0 and plans to introduce significant new products in 2026 [5] - The company is also focusing on expanding its product matrix with new launches in various series, which is expected to optimize revenue structure [7] Financial Metrics - The company's gross margin decreased by 1.8 percentage points to 80.3% in 2025, attributed to changes in product mix and a decline in high-margin medical dressing revenue [6] - The sales, management, and R&D expense ratios were 37.3%, 3.1%, and 1.6% respectively, with an increase in sales expense ratio due to heightened brand investment [6] Future Outlook - The company is expected to return to a growth trajectory through continuous product innovation and expansion in the medical aesthetics sector [7] - The net profit forecasts for 2026 and 2027 have been adjusted to 2.01 billion yuan and 2.37 billion yuan, respectively, reflecting a downward revision of 42% and 47% [7]

Investment Rating - The report assigns a "Buy" rating to the company, with a current price of HKD 6.39 and a fair value of HKD 8.46 [8]. Core Insights - The company achieved a significant revenue growth of 6.9% year-over-year in 2025, with total revenue reaching USD 2.641 billion and a net profit of USD 225 million, reflecting a 12.0% increase [8]. - The company has shown continuous improvement in profitability, with a gross margin of 19.9% and a net margin of 8.5%, both reaching new highs since its listing [8]. - The company is expected to maintain optimistic growth prospects for 2026, supported by strong performance from its largest client, Uniqlo, which accounted for 38% of the company's revenue in the first half of 2025 [8]. - The company has been expanding its client base and enhancing its supply chain, which is expected to further improve its market share and profitability [8]. Financial Summary - Revenue projections for 2024 to 2028 are as follows: - 2024: USD 2.470 billion - 2025: USD 2.641 billion - 2026: USD 2.917 billion - 2027: USD 3.232 billion - 2028: USD 3.579 billion - The expected growth rates for revenue are 13.4% in 2024, 6.9% in 2025, and an average of around 10.5% from 2026 to 2028 [3][11]. - The projected net profit for 2026 is USD 257 million, with an EPS of USD 0.09, and a P/E ratio of 9.1 [3][11]. - The company’s return on equity (ROE) is expected to increase from 13.1% in 2024 to 17.5% in 2028 [3][11].

Investment Rating - The report maintains a "BUY" rating on VSTECS, supported by a solid earnings growth outlook and shareholder return [1][15]. Core Insights - VSTECS reported a total revenue increase of 10% YoY to HK$97.6 billion for FY25, with net profit growing by 29% YoY to HK$1.35 billion, exceeding consensus estimates by 5% [1]. - The management anticipates a net income CAGR of 20% over FY26-28E, driven by operating leverage and increased revenue from self-developed products [1]. - The target price is adjusted to HK$14.00 based on a 12x FY26E P/E, reflecting a potential upside of 77.7% from the current price of HK$7.88 [3]. Financial Performance - FY25 revenue breakdown shows enterprise systems, consumer electronics, and cloud computing revenues growing by 2%, 19%, and 29% YoY, respectively [8]. - Revenue from Southeast Asia increased by 17% YoY to HK$35.8 billion, accounting for 37% of total revenue [8]. - The company plans to double its investment in R&D for self-developed products, expecting revenue growth of approximately 150%, 120%, and 90% YoY for FY26, FY27, and FY28, respectively [8]. Margin and Shareholder Returns - Net profit margin expanded by 0.2 percentage points YoY to 1.5% in FY25, attributed to effective G&A expense control and operating leverage [8]. - An annual dividend of HK$600 million (HK$0.42 per share) was announced, resulting in a dividend yield of 5% [8]. Business Forecasts and Valuation - The revenue forecast for FY26E is set at HK$111.7 billion, with net profit expected to reach HK$1.7 billion, reflecting an 11.9% increase from previous estimates [9]. - The valuation of VSTECS is pegged at HK$14.00 per share, based on a target P/E of 12x for FY26E, aligning with the average P/E of its peers [11].

Investment Rating - The investment rating for the company is set at ★★★★☆ for basic factors and valuation, ★★★★★ for performance growth, ★★☆☆☆ for industry representation, ★★★☆☆ for industry prosperity, and ★★★★☆ for market conditions [4]. Core Insights - The company specializes in collaborative robots designed for industrial automation applications, focusing on research, development, production, and sales of collaborative robots and core motion components [1]. - The collaborative robots are recognized for their high stability, precision, and excellent motion control performance, supporting various applications across multiple industries, including industrial manufacturing, consumer electronics, and healthcare [2]. - The global collaborative robot market is projected to grow from RMB 2.5 billion in 2020 to RMB 7.5 billion by 2024, with a compound annual growth rate (CAGR) of 32.0%, and is expected to reach RMB 35 billion by 2029, with a CAGR of 37.4% [3]. Summary by Relevant Sections Company Overview - The company operates in the collaborative robot sector, which is a distinct category within the broader robotics industry, designed for precise automation in environments requiring close human collaboration [1]. Product Applications - The E-series collaborative robots are primarily used in industrial manufacturing, consumer electronics, and healthcare for high-precision applications such as small component assembly and medical testing. The S-series robots are deployed in the automotive and logistics sectors for tasks like palletizing and material handling [2]. Competitive Advantages - The company boasts six competitive advantages: market recognition in the rapidly growing global collaborative robot industry, integrated software and hardware development capabilities, leading product performance, standardized deployment of collaborative robots for critical applications, collaboration with global industry leaders to build a scenario-based ecosystem, and a strong management team with a solid technical background [2]. Financial Projections - Revenue is projected to grow from RMB 1.09 billion in 2022 to RMB 1.75 billion in 2023, and further to RMB 3.10 billion in 2024. The company is expected to achieve a profit of RMB 0.019 billion in 2023 and RMB 0.18 billion in 2024 [4].

Investment Rating - The report assigns a "Buy" rating to the company, with a current price of HKD 76.70 and a fair value of HKD 93.45 [8]. Core Insights - The company demonstrated growth in both scale and profitability, with total operating revenue and other income reaching USD 2.619 billion in 2025, a 2.4% increase from USD 2.557 billion in 2024. However, net profit after tax decreased to USD 787 million, down 14.8% from USD 924 million in 2024, primarily due to non-recurring items related to aircraft recovery [9][8]. - The fleet and transaction structure have been optimized, with a total of 815 aircraft and engines owned, managed, or ordered by the end of 2025, including 462 owned aircraft, an increase from 446 in 2024. The company delivered 51 new aircraft and engines during the year, exceeding the previous year's deliveries [12][8]. - The rental yield for operating leases improved to 10.3% in 2025 from 10.0% in 2024, while financing lease interest income grew by 12.3% to USD 261 million [16][8]. - The company's total liabilities increased to USD 19.497 billion, a 4.3% rise year-on-year, with a manageable average funding cost of 4.5% [19][8]. - The forecast for 2026 indicates a net profit of USD 982 million, with a revised valuation of 1.1x P/B, corresponding to a fair value of HKD 93.45 per share [22][8]. Financial Summary - **Revenue Forecast**: Projected operating revenue for 2026 is USD 2.868 billion, with a growth rate of 9.52% [3]. - **Net Profit Forecast**: Expected net profit for 2026 is USD 982 million, reflecting a recovery from the previous year's decline [3]. - **Earnings Per Share (EPS)**: EPS is projected to be USD 1.42 in 2026, up from USD 1.13 in 2025 [3]. - **Valuation Ratios**: The P/E ratio is expected to be 6.9 in 2026, while the P/B ratio is projected at 0.9 [3].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 91.00 [1][6][12] Core Insights - The company reported a net profit of USD 787.25 million for 2025, which is an 18% year-on-year increase, exceeding expectations due to strong aircraft disposal gains [6] - The company sold 35 owned aircraft, generating a net gain of USD 213 million, with a profit margin on aircraft sales rising to 15% [6] - The company increased its annual dividend payout ratio from 35% to 40%, enhancing shareholder returns [6] - The company’s capital expenditure reached USD 4.2 billion, the highest since 2020, indicating aggressive asset expansion plans [6][8] Financial Performance - Revenue and other income projections for the upcoming years are as follows: - 2025: USD 2,619 million - 2026E: USD 2,744 million (+4.79%) - 2027E: USD 2,907 million (+5.92%) - 2028E: USD 3,081 million (+6.00%) [5] - The net profit attributable to the parent company is projected to grow to USD 944 million by 2028, with a compound annual growth rate (CAGR) of approximately 8.07% from 2025 to 2028 [5] - The company’s return on equity (ROE) is expected to remain stable around 11.6% in 2026 [9] Market Dynamics - The global demand for passenger traffic is expected to grow by approximately 5%, while supply remains tight, supporting rental rates and aircraft values [6][7] - The company has a robust order backlog of 337 aircraft, with a committed capital expenditure of USD 19.1 billion, positioning it as one of the largest leasing firms globally [8] - The geopolitical situation in the Middle East poses potential short-term disruptions to demand and airline cash flows, with the company currently exposed to 25 aircraft across six airlines in the region [7][8]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 45.00 [1][6]. Core Insights - The company is expected to return to a growth trajectory starting in 2026, driven by brand strengthening and new product approvals in the collagen segment [6][11]. - In 2025, the company achieved revenue of HKD 55.19 billion, a slight decrease of 0.4% year-on-year, with a net profit attributable to the parent company of HKD 19.15 billion, down 7.1% year-on-year [6][11]. - The board proposed a dividend of HKD 0.539 per share, along with a special dividend of HKD 0.6714 [6]. Financial Performance - Revenue projections for 2026 and 2027 are adjusted to HKD 61.27 billion and HKD 69.88 billion, respectively, reflecting a decrease of 30.2% and 33.2% from previous estimates [11][13]. - The gross profit margin is expected to decline slightly to 79.6% for 2026 and 2027, down by 2 percentage points from previous forecasts [11][13]. - The company’s earnings per share (EPS) for 2026 and 2027 are projected at HKD 1.88 and HKD 2.07, respectively [11][19]. Brand and Product Development - The company continues to strengthen its brands, "可复美" and "可丽金," with a focus on enhancing consumer perception and product matrix [7]. - The revenue from the "可复美" brand in 2025 was HKD 44.7 billion, while "可丽金" generated HKD 9.2 billion, showing a year-on-year growth of 9.1% [7][9]. - New product launches, including collagen-based items, are anticipated to contribute to future growth [6][11]. Sales Channels and Market Expansion - In 2025, direct sales and distribution channels generated revenues of HKD 41.4 billion and HKD 13.8 billion, respectively, with direct sales accounting for 74.9% of total revenue [8]. - The company has expanded its market presence internationally, with products entering retail channels in Singapore, Malaysia, and North America [8]. Profitability and Cost Structure - The company's gross margin for 2025 was reported at 80.3%, a decrease of 1.8 percentage points year-on-year, attributed to changes in product mix [10]. - The selling expense ratio increased to 37.3% in 2025, reflecting ongoing investments in brand building [10][11].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative increase in stock price of over 20% compared to the benchmark index within six months [10][16]. Core Insights - The company reported a revenue of RMB 2.913 billion for 2025, marking a year-on-year increase of 30.01%, and a net profit of RMB 634 million, reversing a loss of RMB 398 million from the previous year [5][10]. - The reliance on single IP has decreased, with the contribution from the top four IPs dropping from 91% in 2024 to 81% in 2025, indicating a diversification in revenue sources [6]. - The adult-oriented product segment has seen significant growth, with its revenue share increasing from 11.4% in 2024 to 16.7% in 2025, reflecting the company's expanding brand influence in the adult market [6]. - The introduction of new product categories, such as building block vehicles, has performed well, generating sales of 5.41 billion RMB and accounting for 18.6% of total revenue [7]. Financial Performance - The company achieved a gross margin of 46.8% in 2025, a decrease of 5.8 percentage points from 2024, primarily due to high initial costs associated with new product development and increased logistics costs for overseas market expansion [9]. - Revenue projections for 2026 to 2028 are estimated at RMB 3.8 billion, RMB 4.8 billion, and RMB 6.1 billion, respectively, with expected growth rates of 30%, 27%, and 26% [10][12]. - The adjusted net profit for 2026 is projected to be RMB 817 million, with a year-on-year growth of 29% [10][12]. Market Dynamics - The domestic market revenue for 2025 was RMB 2.594 billion, reflecting a year-on-year growth of 19.19%, while the overseas market revenue surged by 396.6% to RMB 319 million, indicating a significant expansion in international markets [8]. - Online sales channels have shown explosive growth, contributing RMB 253 million in revenue, a 62% increase year-on-year, highlighting the effectiveness of the company's channel optimization strategy [8].

Investment Rating - The investment rating for Alibaba-SW (09988.HK) is maintained at "Buy" [1] Core Views - Strong demand for cloud services and significant investment in AI infrastructure are expected to drive revenue growth, with a target of $100 billion in cloud and AI commercialization revenue over the next five years [1][3] - Short-term focus on stabilizing market share in e-commerce, with flash sales driving user growth and improving order density, which may help reduce losses per order [3] - Adjusted net profit forecasts for FY2026-2028 have been revised down to 78.7 billion, 105.6 billion, and 137.8 billion RMB, reflecting a year-on-year growth of -50.2%, +34.3%, and +30.5% respectively [1][2] Financial Summary and Valuation Metrics - Revenue for FY2026 is projected at 1,174.3 billion RMB, with a year-on-year growth of 17.9% [5] - Non-GAAP net profit for FY2026 is expected to be 78.7 billion RMB, reflecting a significant decline of 50.2% year-on-year [5] - The diluted EPS for FY2026 is estimated at 4.4 RMB, with corresponding P/E ratios of 26.6, 19.5, and 14.6 for FY2026, FY2027, and FY2028 respectively [5]

Investment Rating - The report maintains a positive investment outlook for CK Hutchison Holdings Limited (长江和记实业), indicating a stable investment rating due to its diversified asset portfolio and potential divestment opportunities [2][5]. Core Insights - CK Hutchison is expected to achieve a 3% year-on-year growth in recurring profit to HKD 11 billion for the second half of 2025, with a final dividend increase of 6% to HKD 1.602 per share, exceeding market consensus by 3% [2][3]. - The company is gradually exiting the telecommunications business and is expected to complete port asset disposals, which will enhance corporate value [5]. - The diversified asset portfolio and favorable currency exchange rates are anticipated to support the company's profitability amidst rising energy prices [5]. Summary by Sections Financial Performance - CK Hutchison's recurring profit for the second half of 2025 is projected to grow by 3% to HKD 11 billion, driven by the port, retail, and telecommunications sectors, with support from the appreciation of GBP and EUR [3]. - The final dividend is expected to increase by 6% to HKD 1.602 per share, maintaining a stable payout ratio of 40% of underlying earnings [3]. Shareholder Returns - Despite a strong balance sheet and cash flow, the likelihood of increasing shareholder returns in the short term is considered low, with management indicating a focus on maintaining flexibility for potential acquisitions amid geopolitical uncertainties [4]. Investment Logic - The investment rationale remains unchanged, focusing on the diversified asset portfolio and potential divestment opportunities, which are expected to mitigate uncertainties and provide a buffer against profit margin pressures from rising energy prices [5]. - Key catalysts for growth include asset disposals, large-scale share buybacks, and increased dividends [6].